European Journal of Radiology
Volume 42, Issue 1 , Pages 10-16 , April 2002

Fine needle aspiration cytology versus percutaneous biopsy of nonpalpable breast lesions

  • M Meunier

      Affiliations

    • Department of Radiology, Institut Curie, 26 rue d'Ulm, 75231 Paris Cedex 05, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-1-4432-4200; fax: +33-1-4432-4015
    • ,
  • K Clough

      Affiliations

    • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75231 Paris Cedex 05, France

Received 27 November 2001 ,Accepted 28 November 2001.

References 

  1. The uniform approach to breast fine needle aspiration biopsy. The final version. Breast J 1997;3(4):148–68.
  2. Azavedo E, Svane G, Auer G. Stereotactic fine needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet. 1989;1:1033–1036
  3. Meunier M, Le Gal M, Klijanienko J, Vielh P, Neuenschwander S, Durand JC, et al. Diagnostic des lésions mammaires non palpables: apport des ponctions cytologiques après repérage stéréotaxique. J. Radiol. 1995;76:259–262
  4. Sneige N, Fornage BD, Saleh G. Ultrasound-guided fine-needle aspiration of non palpable breast lesions. Am. J. Clin. Pathol. 1994;102:98–101
  5. Thibault F, Meunier M, Klijanienko J, El Khoury C, Nos C, Vincent-Salomon A, et al. Diagnostic accuracy of sonography and combined sonographic assessment and sonographically guided cytology in nonpalpable solid breast lesions. J. Clin. Ultrasound. 2000;28:387–398
  6. Verkooijen HM, Peeters PHM, Buskens E, Borel Rinkes IHM, Mali WPThM, Vroonhoven ThJMV. Diagnosis accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis. Br. J. Cancer. 2000;82:1017–1021
  7. Sneige N. Specimen adequacy and false-negative diagnosis rate in FNA aspirates of palpable masses. Cancer. 1998;84:344–348
  8. Sneige N. Fine needle-aspiration of the breast: a review of 1995 cases with emphasis on diagnostic pitfalls. Diagn. Cytopathol. 1993;9:106–112
  9. Mitnick JS, Vasquez MF, Feiner HD, Pressman P, Roses DF. The clinical significance of cytologic atypia in stereotactic fine needle aspiration biopsies of mammogram-detected breast lesions. Radiology. 1996;198:319–322
  10. Fajardo LI, Davis JR, Wiens JL, Trego DC. Mammographically-guided stereotactic fine needle aspiration cytology of nonpalpable breast lesions prospective comparison with surgical biopsy results. Am. J. Roentgenol. 1990;198:319–322
  11. Mitnick JS, Vasquez MF, Feiner HD, Pressman P, Roses DF. The clinical significance of cytologic atypia in stereotactic fine needle aspiration biopsies of mammogram-detected breast lesions. Radiology. 1996;198:319–322
  12. Abendroth CS, Wang HH, Ducatman BS. Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine needle aspiration biopsy specimens. Am. J. Clin. Pathol. 1991;96:654–659
  13. Thomas PA, Cangiarella J, Raab SS, Waisman J. Fine needle aspiration biopsy of proliferative breast disease. Mod. Pathol. 1995;8:130–136
  14. Sneige N, Staerkel GA. Fine needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. Hum. Pathol. 1994;25:485–492
  15. Sidawy MK, Stoler MH, Frable WJ, Frost AR, Massood S, Miller TR, et al. Interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Study. Diagn. Cytopathol. 1998;18:150–165
  16. Burbank F, Parker SH. Methods for evaluating the accuracy the quality of an image-guided breast biopsy program. Semin. Breast Dis. 1998;1:71–83
  17. Jackman R, Burbank F, Parker S, Evans W, Lechner MC, Richardson T, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology. 2001;218:497–502
  18. Darling ML, Smith DN, Lester SC, Kaelin C, Selland DL, Denison CM, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. Am. J. Roentgenol. 2000;175:1341–1346
  19. Philpotts LE, Lee CH, Horvath LJ, Lange RC, Carter D, Tocino I. Underestimation of breast cancer with 11-gauge vacuum suction biopsy. Am. J. Roentgenol. 2000;175:1047–1050
  20. Jacobs TW, Siziopikou KP, Prileau JE, Baum JK, Hayes DF, Schnitt SJ. Do pronostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?. Mod. Pathol. 1998;11:259–264
  21. Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod. Pathol. 1999;12:941–945
  22. Homer MJ, Safaii H, Smith TJ, Marchant DJ. The relationship of mammographic microcalcification to malignancy: radiologic–pathologic correlation. Am. J. Roentgenol. 1989;153:1187–1189
  23. Liberman L, Dershaw DD, Rosen PP, Morris EA, Abramson AF, Borgen PI. Percutaneous removal of malignant mammographic lesions at stereotactic vacuum-assisted biopsy. Radiology. 1998;206:711–715
  24. Boppana S, May M, Hoda S. Does prior fine-needle aspiration cause diagnostic difficulties in histologic evaluation of breast carcinomas(abstract). Lab. Invest. 1994;70:13A
  25. Youngson BJ, Cranor M, Rosen PP. Epithelial displacement in surgical breast biopsies following needles procedures. Am. J. Surg. Pathol. 1994;18:896–903
  26. Youngson BJ, Liberman L, Rosen PP. Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am. J. Clin. Pathol. 1995;103:598–602
  27. Diaz LK, Wiley EL, Venta LA. Are malignant cells displaced by large-gauge needle core biopsy of the breast?. Am. J. Roentgenol. 1999;173:1303–1313
  28. Pisano E, Fajardo LL, Tsimikas J, Sneige N, Frable WJ, Gatsonis CA, et al. Rate of insufficient samples for fine needle aspiration for nonpalpable breast lesions in a multicenter trial. Cancer. 1998;82:679–688
  29. Pal S, Ikeda DM, Birdwell RL. Compliance with recommended follow-up after fine-needle aspiration biopsy of non palpable breast lesions: a retrospective study. Radiology. 1996;201:71–74
  30. Parker SH, Burbank F, Jackman RJ, Aucreman CJ, Cardenosa G, Cink TM, et al. Percutaneous large-core biopsy: a multi-institutional study. Radiology. 1994;193:359–364
  31. Brenner RJ, Fajardo L, Fisher PR, Dershaw DD, Evans WP, Bassett L, et al. Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. Am. J. Roentgenol. 1996;166:341–346
  32. March DE, Raslavicus A, Coughlin BF, Klein SV, Makari-Judson G. Use of breast core biopsy in the United States; results of a national survey. Am. J. Roentgenol. 1997;169:697–701
  33. Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD. The breast Imaging Reporting and Data System: positive predictive value of mammographic features and final assessment categories. Am. J. Roentgenol. 1998;171:35–40
  34. Cyrlak D. Induced costs of low-cost screening mammography. Radiology. 1988;168:661–663
  35. Ciatto S, Cecchini S, Grazzini G, Iosa A, Bartoli D, Cariaggi MP, et al. Positive predictive value of fine needle aspiration cytology of breast lesions. Acta Cytol. 1989;33:894–898
  36. Liberman L, Fahs MC, Dershaw DD, Bonaccio E, Abramson AF, Cohen MA, et al. Impact of stereotaxic core biopsy on cost of diagnosis. Radiology. 1995;195:633–637
  37. Lee CH, Egglin TIK, Philipotts LE, Maineniero MB, Tocino I. Cost effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model. Acad. Radiol. 1996;3:351–360
  38. Liberman L, Feng TL, Dershaw DD, Morris EA, Abramson AF. Ultrasound-guided core breast biopsy: utility and cost-effectiveness. Radiology. 1998;208:717–723
  39. Brenner RJ, Sickles EA. Surveillance mammography and stereotactic core breast biopsy for probably benign lesions: a cost comparison analysis. Acad. Radiol. 1997;6:419–425
  40. Smith DN, Christian R, Meyer JE. Large-core needle biopsy of nonpalpable breast cancers: the impact on subsequent surgical excision. Arch. Surg. 1997;132:256–259
  41. Liberman L, LaTrenta LR, Dershaw DD, Abramson AF, Morris EA, Cohen AA, et al. Impact of core biopsy on the surgical management of impalpable breast cancer. Am. J. Roentgenol. 1997;168:495–499
  42. Jackman RJ, Marzoni FA, Finkelstein SI, Shepard MJ. Benefits of diagnosing nonpalpable breast cancer with stereotactic large-core needle biopsy: lower costs and fewer operations(abst). Radiology. 1996;201(P):311
  43. Liberman L, Cody HS, Hill AD, Rosen PP, Yeh SD, Akhurst T, et al. Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer. Radiology. 1999;211:835–844

PII: S0720-048X(01)00480-6

European Journal of Radiology
Volume 42, Issue 1 , Pages 10-16 , April 2002

Article Tools